Vonorasan Fumarate Injection (Shandong New Time Pharmaceutical)

富马酸伏诺拉生注射液 (山东新时代药业有限公司)

Report date: 2025/03/10 20:00:41

Base Information

Drug NameVonorasan Fumarate Injection (Shandong New Time Pharmaceutical)
Drug Alias NameVonora fumarate
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium-transporting ATPase inhibitors
TargetsPotassium-transporting ATPase
Therapy Area/IndicationsPeptic UlcerPeptic Ulcer Hemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPeptic Ulcer Hemorrhage
Inactive IndicationsPeptic Ulcer

Other Information

ATC CodeN/A
Related LinksN/A